Natalia Honchar

According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences companies in the categories "startups" and "scaleups" are actively using machine learning and deep learning-based predictive and generative capabilities …

When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery in the first place. Indeed, as it was captured and analyzed in the report The Landscape of Artificial Intelligence (AI) …

Our cells function in the continuous mode of producing and degrading proteins, keeping the balance between these two processes to maintain a healthy cellular function. However, sometimes the produced proteins might be defective, accumulating and causing pathological effects. This is …

Are there alternatives to using animals in drug discovery? Even though right now it still seems like a milestone which is almost impossible to avoid, there is a way to not only save the animal lives, but also enhance the …

Drug delivery technologies often become a remedy and a solution for various drugs on their way to clinical approval. When the drug is developed, whether it is a small molecule, peptide, nucleic acid, antibody, or even the whole living cell, …

Scandinavian countries are known for their active innovation in the worldwide market, including pharmaceutical and biotech fields. Numerous research institutes, start-up incubators, and grant opportunities give rise to active drug development, medical device innovation, and implementation of machine learning (ML) …

Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) and quantum computing in life sciences.

(Last updated: October 05, 2022)

The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their internal screening programs using DELs or outsourcing capabilities from specialized DEL …

Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. But is “nano” defined just by the size? According to FDA, nanomedicines are the products in the nanoscale range (meaning …

Auron Therapeutics, a biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular plasticity for treating cancer, just announced the completion of its $48 million Series A financing round. Proceeds will be used to advance the lead program …